Get the Stockscreener App
2.79
0.72%
0.02
Bioharvest Sciences Inc stock is traded at $2.79, with a volume of 3,476.
It is up +0.72% in the last 24 hours and down -27.72% over the past month.
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. The Company has two operating segments or business units: the Products business unit and the CDMO Services business unit. In identifying these operating segments, management generally follows the Company's service lines representing its main products and services. The Products Business Unit - Nutraceuticals: Research, development, manufacturing, marketing and sales of science-based health and wellness nutraceutical solutions which are manufactured and sold as dietary supplements, functional food and beverages. The CDMO Services Business Unit - comprising a Contract Development and Manufacturing Operation that offers pharmaceuticals, cosmeceuticals, nutraceuticals, and nutritions.
See More
Previous Close:
$2.77
Open:
$2.75
24h Volume:
3,476
Relative Volume:
0.12
Market Cap:
$63.24M
Revenue:
$35.16M
Net Income/Loss:
$-11.44M
P/E Ratio:
-4.6804
EPS:
-0.5961
Net Cash Flow:
$-15.44M
1W Performance:
-8.52%
1M Performance:
-27.72%
6M Performance:
-46.35%
1Y Performance:
-58.42%
1-Day Range:
$2.75
$2.82
1-Week Range:
$2.745
$3.3913
52-Week Range:
$2.745
$12.80
Bioharvest Sciences Inc Stock (BHST) Company Profile
Name
Bioharvest Sciences Inc
Sector
Industry
Phone
-
Address
-
Compare BHST vs JBS, KHC, GIS, HRL, MKC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BHST
Bioharvest Sciences Inc
|
2.79 | 62.79M | 35.16M | -11.44M | -15.44M | -0.5961 |
JBS
Jbs Nv
|
12.22 | 40.19B | 88.25B | 1.91B | -681.64M | 1.6761 |
KHC
Kraft Heinz Co
|
24.19 | 28.10B | 24.99B | -5.76B | 3.95B | -4.863 |
GIS
General Mills Inc
|
36.38 | 19.22B | 18.37B | 2.22B | 1.65B | 4.0676 |
HRL
Hormel Foods Corp
|
26.31 | 14.59B | 12.22B | 466.64M | 692.94M | 0.8477 |
MKC
Mccormick Co Inc
|
52.06 | 13.72B | 7.11B | 1.65B | 680.40M | 6.1005 |
Bioharvest Sciences Inc Stock (BHST) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-19-26 | Initiated | Roth Capital | Buy |
| May-05-25 | Initiated | Craig Hallum | Buy |
| Dec-18-24 | Initiated | Maxim Group | Buy |
Bioharvest Sciences Inc Stock (BHST) Latest News
BioHarvest Sciences, Inc. Actuals & Estimates (MUN:8MV0) - TradingView
BioHarvest Sciences Inc. (BHST) reports Q1 loss, beats revenue estimates - MSN
BioHarvest Sciences, Inc. Actuals & Estimates (NASDAQ:BHST) - TradingView
Bioharvest Sciences Inc (BHST) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
BioHarvest Sciences, Inc. Actuals & Estimates (DUS:8MV0) - TradingView
BioHarvest Sciences, Inc. Actuals & Estimates (LS:A40C6G) - TradingView
Bioharvest Sciences Inc (BHST) Valuation: PE, PB & Fair Value Analysis - TradingKey
Bioharvest Sciences Inc (BHST) Institutional Confidence - TradingKey
Bioharvest Sciences Inc (BHST) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
BioHarvest Sciences to Showcase Botanical Synthesis at 2026 BIO International Convention - The Globe and Mail
BioHarvest Sciences (BHST) to showcase Botanical Synthesis at 2026 BIO Convention - Stock Titan
Bioharvest Sciences Inc (BHST) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Bioharvest Sciences Inc (BHST) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
BioHarvest brings its plant-based tech to BIO International in San Diego - Stock Titan
BioHarvest Sciences to present botanical synthesis platform at BIO International Convention - Proactive financial news
Bioharvest Sciences Inc (BHST) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Bioharvest Sciences Inc (BHST) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Bioharvest Sciences Inc (BHST) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
BioHarvest Sciences Inc. (BHST) Q1 2025 Earnings: EPS Misses Estimates as Company Continues Strategic AdvancementManagement Guidance Update - newsline.com
BHST PE Ratio & Valuation, Is BHST Overvalued - Intellectia AI
BioHarvest Sciences Q1 2025 Earnings: EPS Misses Estimates While Stock Sees Positive ReactionSegment Revenue Breakdown - newsline.com
BioHarvest Sciences Inc. (BHST) Advances 2.75% as Shares Hold Above Key SupportLong Setup Ideas - newsline.com
BioHarvest Sciences Inc. (BHST) Q1 2025 Earnings: Higher Losses Weigh on Operational ProgressEarnings Preview - newsline.com
Analysts Have Conflicting Sentiments on These Consumer Goods Companies: BioHarvest Sciences (BHST) and Brown Forman A (BF.A) - The Globe and Mail
BioHarvest Sciences (BHST) Gains Nearly 1% as Shares Test Key ResistanceUp Down Ratio - newsline.com
BioHarvest Sciences Inc. (BHST) Q1 2025 Earnings: EPS Misses Estimates, Stock DeclinesPerformance Review - newsline.com
BHST Q1 2025 Earnings: EPS Misses Estimates, Stock DeclinesEarnings Revision Upgrade - newsline.com
BioHarvest (BHST) Q4 2025 Earnings Transcript - AOL.com
BioHarvest Sciences (BHST) Retreats to Key Support Level After Modest DeclineElliott Wave Count - newsline.com
BioHarvest Sciences Files Form 6-K With Meeting Materials for Upcoming Shareholder Vote - TipRanks
BioHarvest Sciences (BHST) schedules 2026 AGM to elect board and ratify auditor - Stock Titan
BioHarvest Sciences Inc. (BHST) Edges Higher as Price Approaches Resistance After Support TestHigh Dividend Factor - The Legal Advocate
Tate & Lyle expands BioHarvest partnership for next-gen sweetener innovation - FoodTechBiz
BioHarvest Sciences Inc. (BHST) Edges Higher as Trading Volume Picks UpPercent Above MA - The Legal Advocate
BioHarvest Sciences Inc. (BHST) Finds Support, Bounces to $3.86Double EMA - The Legal Advocate
Tate & Lyle Expands Collaboration with BioHarvest Sciences to Accelerate Next-Generation Sweetener Innovation - TMX Newsfile
BioHarvest Sciences (BHST) Q1 2025 Earnings: EPS Misses Estimates as Company Navigates Early-Stage CommercializationRevenue Inflection Point - The Legal Advocate
Bioharvest Sciences Signals Progress Amid Near-Term Losses - TipRanks
BioHarvest Sciences and Tate & Lyle expand sweetener development program - Yahoo! Finance Canada
Tate & Lyle expands collaboration with BioHarvest to accelerate next-generation sweetener innovation - Asia Food Journal
BioHarvest (BHST) Q1 2026 Earnings Transcript - AOL.com
BioHarvest expands Tate & Lyle sweetener development deal By Investing.com - Investing.com Australia
Tate & Lyle expands plant-based sweetener innovation partnership with BioHarvest Sciences - New Food
BioHarvest expands Tate & Lyle sweetener development deal - Investing.com UK
Bioharvest Sciences Inc Stock (BHST) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.19%
0.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):